1. Differential biomarker profiles between unprovoked venous thromboembolism and cancer
- Author
-
F. J. Rodríguez-Martorell, Aitor Ballaz-Quincoces, Maribel Asensio-Cruz, Lin Gao, Remedios Otero-Candelera, José Luis López-Campos, J. L. Lobo-Beristain, Teresa Elias-Hernandez, Marta Ferrer-Galvan, M. J. Castro-Pérez, Luis Jara-Palomares, Elena Arellano-Orden, Verónica Sánchez-López, Virtudes Vila-Liante, Instituto de Salud Carlos III, Junta de Andalucía, and Instituto de Investigación Sanitaria La Fe (España)
- Subjects
Male ,Oncology ,medicine.medical_specialty ,pulmonary embolism ,030204 cardiovascular system & hematology ,Thromboplastin ,Fibrin Fibrinogen Degradation Products ,Extracellular Vesicles ,03 medical and health sciences ,0302 clinical medicine ,Venous thromboembolic disease ,Neoplasms ,Thromboembolism ,Internal medicine ,D-dimer ,medicine ,Humans ,cancer ,Prospective Studies ,cellular extravesicles ,030212 general & internal medicine ,Aged ,Cancer ,Membrane Glycoproteins ,business.industry ,Pulmonary embolism ,Original Articles ,General Medicine ,Middle Aged ,medicine.disease ,Thrombosis ,Cellular extravesicles ,Coagulation ,Case-Control Studies ,Biomarker (medicine) ,Female ,P-selectin ,business ,Venous thromboembolism ,Biomarkers - Abstract
[Background]: The relationship between cancer and venous thromboembolic disease (VTD) are complex because the activated coagulation factors are not only involved in thrombosis but also in malignant processes, such as angiogenesis and metastasis., [Objective]: To compare phenotypes of extracellular vesicles (EVs), and levels of D-dimer, soluble P-selectin (sP-selectin) and antigenic tissue factor (TF) between unprovoked VTD patients, who did not develop cancer during one-year follow-up, and those with advanced stage of cancer but not associated with VTD., [Methods]: A prospective study in which we included 138 unprovoked VTD patients and 67 advanced cancer patients, who did not develop thrombosis. Levels of EVs of different cellular origin (platelet, endothelium and leukocyte), EVs positive for tissue factor (TF) and P-selectin glycoprotein ligand 1 were quantified by flow cytometry. D-dimer, soluble P-selectin (sP-selectin) and antigenic TF were determined by ELISA., [Results]: TF-positive EVs, D-dimer, and sP-selectin were markedly elevated in unprovoked VTD patients compared to cancer patients without association with thrombosis., [Conclusions]: Levels of TF-positive EVs, D-dimer and sP-selectin are able to discriminate between unprovoked VTD patients not related to cancer and cancer patients not associated with VTD. These results could lead to the application of EVs as biomarkers of both diseases., This work was supported by research grants from the Plan Nacional de Investigacion Cient ıfica, Desarrollo e Innovacion Tecnologica (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria [PI11/02308], Red RIC [RD12/0042/ 0029], Junta de Andalucıa [CVI-6654] and by the Fundacion Investigacion Hospital La Fe, Spain.
- Published
- 2020
- Full Text
- View/download PDF